New Alternative Formats vs Standard of SoF Tables. Non-inferiority Controlled Trial
NCT02022631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 290
Last updated 2021-12-13
Summary
The investigators will conduct a parallel two-armed, non-inferiority randomized trial comparing new alternative formats of summary of findings tables (SoF) tables with current formats. The investigators will contact Cochrane review users by email and will ask them to fill a questionnaire developed using the "Survey Monkey" online system. The survey will include questions about baseline information (demographic characteristics, background, number of visits to the Cochrane Library, familiarity with the GRADE system, etc.). Then, participants will be stratified (health professional, guideline developer, researcher) and randomly assigned to one of the two SoF table formats, either the alternative (Table A) or the current one (Table C). Participants will be asked to answer questions to determine understanding, accessibility, and satisfaction with the formats to which they were randomized. Finally, the investigators will show them the table format to which they were not initially allocated in order to test their preference for either one.
Conditions
- GRADE Approach
- Summary of Findings Table
- Cochrane Collaboration
Interventions
- OTHER
-
Alternative summary of findings table format
Investigators will compare one SoF table with alternative formats (Table A) against one SoF table with the current formats (Table B). In both tables, the clinical question in terms of patients and setting, intervention, comparator, and outcomes informed by the tables, and the complementary information included as footnotes will be the same. The only differences between the current and alternative SoF table formats will be different methods to either show the same data in a different way or to provide complementary data to the one showed in the current format (i.e. supplementary data as risk difference).
- OTHER
-
Current summary of findings table format
Investigators will compare one SoF table with alternative formats (Table A) against one SoF table with the current formats (Table B). In both tables, the clinical question in terms of patients and setting, intervention, comparator, and outcomes informed by the tables, and the complementary information included as footnotes will be the same. The only differences between the current and alternative SoF table formats will be different methods to either show the same data in a different way or to provide complementary data to the one showed in the current format (i.e. supplementary data as risk difference).
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Holger Schünemann, MD, MSc, PhD · McMaster University
-
Alonso Carrasco-Labra, DDS, MSc · McMaster University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Canada
Study Locations
More Related Trials
-
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza
NCT00640302 ·Status: WITHDRAWN
-
LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
NCT05077332 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study
NCT06006611 ·Status: UNKNOWN
-
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
NCT04532931 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza
NCT02561169 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19
NCT04346628 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults
NCT02008344 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
NCT04405076 ·Status: COMPLETED ·Phase: PHASE2
-
Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
NCT05085574 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19
NCT05908071 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
NCT04292730 ·Status: COMPLETED ·Phase: PHASE3
-
Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning
NCT06052527 ·Status: COMPLETED
-
Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
NCT05633420 ·Status: COMPLETED ·Phase: PHASE2
-
An Adaptive Clinical Trial of Antivirals for COVID-19 Infection
NCT04445467 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
NCT02469298 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza
NCT00640874 ·Status: WITHDRAWN
-
Effectiveness of Ammonium Chloride in Reducing Viral Load
NCT07254052 ·Status: COMPLETED
-
Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients
NCT05596045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients
NCT05077969 ·Status: TERMINATED ·Phase: PHASE2
-
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
NCT01728753 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Real World COVID-19 Antiviral Effectiveness Research
NCT05638919 ·Status: UNKNOWN
-
The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497
NCT03726853 ·Status: COMPLETED ·Phase: PHASE2
-
Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients
NCT05749445 ·Status: UNKNOWN
-
Efficacy of Favipiravir Against Severe Ebola Virus Disease
NCT02662855 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics,Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A
NCT06656026 ·Status: COMPLETED ·Phase: PHASE2